Editor’s note: This is one of our Startups to Watch of 2022. See the rest here.
Startups to Watch fans will recognize Ajay Kori, the serial entrepreneur who appeared on last year’s list for Allay Lamp, his startup with a device to help alleviate migraines and reduce anxiety. Now he has another company worth keeping on the radar: Novilla Pharmaceuticals Inc.
The early-stage biotech, founded in 2019, aims to end the opioid epidemic with a Harvard University-born technology that can change the way drugs are delivered.
Novilla, which licensed the platform from the former Harvard professors who developed it, bought all of the intellectual property “because of its potential,” Kori told us. It delivers drugs below the skin to target a specific spot on the body, rather than via a pill that works systemically throughout. The goal here is to eliminate adverse side effects while benefiting the organ or area that requires the therapy. Novilla’s pipeline includes “potential blockbuster…
Read the full story from the Washington Business Journal.
